vaccin
design
effort
human
immunodefici
viru
hiv
greatli
stimul
observ
mani
infect
patient
eventu
develop
highli
potent
broadli
neutral
antibodi
bnab
importantli
bnab
evolv
recogn
two
protein
compon
viral
envelop
protein
env
also
numer
glycan
form
protect
barrier
env
protein
env
vastli
overglycosyl
compar
host
glycoprotein
glycan
becom
target
antibodi
respons
therefor
consider
effort
made
develop
valid
biophys
method
elucid
complex
structur
env
spike
glycoprotein
combin
glycan
protein
epitop
illustr
applic
robust
biophys
method
transform
understand
structur
function
hiv
env
spike
stimul
innov
vaccin
design
strategi
take
account
essenti
glycan
compon
determin
high
resolut
structur
viral
attach
fusion
glycoprotein
emerg
critic
step
develop
immun
strategi
tradit
vaccin
approach
fail
current
effect
vaccin
human
immunodefici
viru
aid
goal
sustain
effort
mount
mani
year
deciph
threedimension
structur
heavili
glycosyl
hiv
envelop
spike
env
env
consist
trimer
heterodim
viral
compon
sole
target
neutral
antibodi
env
respos
virion
attach
fusion
target
cell
first
bind
host
cell
surfac
protein
primari
receptor
chemokin
receptor
act
coreceptor
receptor
engag
lead
fusion
viral
host
cell
membran
cell
entri
process
imped
differ
stage
antibodi
howev
substanti
divers
rna
viru
driven
errorpron
revers
transcriptas
mean
host
antibodi
respons
ultim
ineffect
elimin
case
control
infect
establish
especi
hiv
retroviru
notwithstand
vaccin
design
effort
greatli
propel
discoveri
rapidli
grow
arsen
antibodi
isol
infect
patient
show
extraordinari
neutral
potenc
wide
rang
clinic
isol
one
major
longterm
goal
hiv
research
deciph
structur
antibodyenv
complex
aid
effort
design
immunogen
abl
elicit
broadli
neutral
antibodi
bnab
vaccin
mani
studi
anim
model
demonstr
antibodi
present
prior
infect
high
enough
concentr
abl
provid
protect
viral
challeng
rel
recent
key
limit
elucid
epitop
bnab
avail
stabl
recombin
mimic
viral
env
spike
prefus
conform
spike
metast
prone
conform
rearrang
shed
phenomena
particularli
signific
almost
bnab
specif
recogn
env
nativ
conform
mani
depend
quaternari
structur
trimer
furthermor
env
spike
undergo
furinmedi
matur
egress
golgi
apparatu
attain
correct
prefus
conform
final
although
accumul
high
densiti
glycan
env
surfac
mechan
evad
host
antibodi
respons
bnab
still
abl
recogn
dens
glycosyl
differ
substanti
host
protein
thu
activ
area
investig
determin
extent
recombin
mimic
viral
spike
emul
glycan
process
nativ
infecti
virion
design
express
valid
candid
immunogen
exhibit
nativelik
trimer
env
structur
key
goal
hiv
structur
biolog
despit
appar
sophist
current
methodolog
significantli
diverg
structur
report
env
spike
year
similarli
diverg
occur
analyt
character
glycan
chromatograph
mass
spectrometr
method
discuss
rigor
valid
process
led
unambigu
conclus
sosip
platform
bestinclass
solubl
cleav
recombin
mimic
env
spike
show
biophys
method
use
analysi
identifi
correctli
fold
env
structur
versu
misfold
extens
natur
sequenc
divers
accommod
also
discuss
conserv
overal
env
architectur
substanti
shape
glycan
process
lead
remark
homogen
glycan
compon
env
protein
becom
target
antibodi
recognit
design
express
recombin
env
central
antibodybas
vaccin
effort
prerequisit
biophys
analysi
unlik
influenza
exampl
hiv
virion
display
low
densiti
viral
spike
extract
viru
particl
appreci
yield
therefor
strategi
proteas
releas
nativ
viral
glycoprotein
yield
first
gener
influenza
hemagglutinin
structur
readili
appli
hiv
thu
develop
recombin
express
system
produc
properli
fold
trimer
prerequisit
structur
analysi
addit
metast
natur
hiv
env
spike
well
viral
spike
meant
initi
effort
isol
trimer
materi
fail
yield
nativelik
materi
use
trimer
motif
foldon
scaffold
highli
success
produc
influenza
hemagglutinin
trimer
exampl
combin
modif
sequenc
prevent
cleavag
result
properli
fold
trimer
foldonbas
hiv
oligom
also
display
poor
antigen
bnab
react
antibodi
recogn
nonneutr
epitop
nativ
oligomer
interfac
disord
natur
foldonbas
immunogen
vividli
reveal
electron
microscopi
overcom
barrier
recombin
product
nativelik
trimer
princip
metast
shed
trimer
develop
contain
mutat
trap
glycoprotein
nativelik
prefus
state
firstli
disulphid
bond
ad
subunit
term
so
remark
achiev
absenc
structur
inform
use
page
elisa
bind
limit
antihiv
antibodi
avail
time
secondli
increas
trimer
stabil
engin
substitut
prolin
term
ip
order
destabil
helic
postfus
conform
enhanc
format
prefus
trimer
nativ
trimer
requir
matur
furin
cleavag
furin
cleavag
investig
cellular
vitro
context
maxim
cleavag
observ
endogen
cleavag
activ
supplement
coexpress
recombin
furin
negativestain
electron
microscopi
nsem
prove
valuabl
tool
screen
wide
panel
isol
contain
sosip
mutat
includ
truncat
posit
prior
transmembran
region
elimin
hydrophob
membraneproxim
extern
region
goal
determin
possibl
strain
candid
produc
reason
quantiti
cleav
stabl
recombin
env
glycoprotein
structur
studi
clade
strain
select
screen
shown
negativestain
em
fold
compact
order
trimer
display
threefold
symmetri
result
clade
first
inclass
catalys
structur
elucid
env
spike
initi
negativestain
em
high
resolut
cryoem
xray
crystallographi
subsequ
sosip
format
appli
rang
trimer
differ
strain
clade
b
clade
c
howev
sosip
mutat
suffici
guarante
nativelik
trimer
structur
strain
subtyp
hiv
care
antigen
biophys
analysi
necessari
step
valid
new
oligomer
materi
recombin
trimer
platform
part
deriv
sosip
templat
sinc
develop
review
histori
sosip
trimer
current
state
pleas
see
high
densiti
glycosyl
across
env
spike
pose
special
challeng
structur
analysi
glycosyl
protein
notori
chemic
conform
heterogen
best
limit
util
crystallographi
extent
cryoem
reli
averag
signal
mani
thousand
molecul
reveal
consensu
structur
worst
xray
crystallograph
analysi
complet
preclud
extens
divers
glycosyl
prevent
crystal
limit
diffract
cryoem
crystallograph
analysi
env
greatli
enhanc
avail
method
control
glycosyl
process
exampl
first
structur
core
achiev
use
insect
cell
express
system
result
paucimannosetyp
oligomannosetyp
hereaft
refer
simpli
structur
could
readili
cleav
endoglycosidas
endo
h
glycan
cleavag
aid
structur
analysi
core
varieti
method
develop
trap
glycan
cleavabl
form
use
mammalian
express
system
howev
given
import
glycan
within
epitop
bnab
increasingli
common
attempt
preserv
much
glycan
shield
one
end
scale
minim
glycosyl
scaffold
develop
present
glycan
epitop
one
exampl
engin
outer
domain
region
display
loop
term
complex
fab
bind
glycan
minim
glycosyl
structur
typic
exhibit
substanti
chemic
heterogen
express
cell
devoid
glcnac
transferas
gnt
activ
express
system
stall
process
glycan
result
oligomannosetyp
glycan
domin
interestingli
complex
crystal
isol
sizeexclus
chromatographi
result
structur
reveal
extens
densiti
larger
suggest
glycoform
enrich
purif
complex
similar
strategi
employ
determin
structur
epitop
contain
within
scaffold
construct
case
smallmolecul
inhibitor
swainsonin
use
imped
glycan
process
golgi
ii
gener
socal
hybridtyp
glycan
glycan
share
core
contain
glycan
process
one
arm
glycan
exhibit
fucosyl
glcnac
proxim
coval
link
asparagin
residu
protein
surfac
similar
complex
describ
complex
enrich
homogen
glycan
case
hybridtyp
glycan
end
scale
abil
engin
glycan
sensit
endoglycosidas
exploit
elucid
first
crystal
structur
solubl
ectodomain
trimer
env
spike
express
gntidefici
cell
complex
antibodi
bind
composit
glycan
protein
epitop
subject
glycan
cleavag
endoh
cleav
glycan
protect
antibodi
complex
tertiaryquaternari
structur
howev
substanti
fraction
glycan
protect
bound
antibodi
particularli
two
fab
use
xray
structur
determin
combin
two
fab
bound
either
end
trimer
found
abl
domin
crystal
lattic
contact
xray
structur
trimer
made
possibl
solv
structur
clade
g
clade
clade
b
strain
jrfl
trimer
fulli
intact
oligomannosetyp
glycoform
structur
show
extens
densiti
glycan
although
mani
conserv
glycan
differ
appar
conform
across
structur
consist
conform
flexibl
glycan
env
trimer
util
use
fab
domin
lattic
contact
demonstr
structur
trimer
express
cell
nativelik
glycosyl
reveal
epitop
hitherto
undisclos
bind
site
antibodi
also
requir
deliber
glycan
engin
depend
fraction
isol
size
exclus
purif
complex
certain
glycoform
trimer
appear
differ
suggest
heterogen
within
singl
sosip
trimer
prepar
result
electron
densiti
challeng
simplist
understand
structur
glycan
shield
least
result
glycan
structur
differ
character
mass
spectrometri
glycopeptid
deriv
env
protein
gristick
et
al
provid
appropri
caveat
analysi
discrep
suggest
either
substanti
enrich
particular
sosip
glycoform
crystal
interpret
glycan
extens
stabil
interact
protein
surfac
lead
incorrect
infer
underli
glycan
composit
glycan
part
nearli
everi
bnab
epitop
also
influenc
choic
bnab
purif
immuneaffin
captur
exampl
viru
neutral
two
popular
antibodi
reagent
use
env
purif
correspond
solubl
sosip
env
trimer
made
viru
unlik
abl
purifi
use
antibodi
unless
epitop
engin
construct
anoth
altern
purif
reagent
sensit
quaternari
integr
env
trimer
despit
differ
antigen
site
way
one
purifi
env
trimer
part
independ
trimer
purif
strategi
much
depend
proper
quaternari
structur
env
global
trend
appear
consist
site
specif
minor
differ
may
result
use
differ
approach
structur
env
trimer
xray
crystallographi
took
mani
year
studi
first
initi
advent
earli
version
jrfl
sosip
trimer
construct
crystal
obtain
diffract
low
resolut
identif
critic
breakthrough
obtain
high
resolut
xray
em
structur
resolut
crystal
structur
third
gener
env
trimer
exhibit
anisotropi
xray
diffract
limit
overal
resolut
glycan
heterogen
also
major
issu
deglycosyl
env
trimer
presenc
bnab
remov
mani
sugar
protect
bnab
quaternari
tertiari
contact
protein
overal
strategi
determin
env
trimer
structur
xray
crystallographi
use
differ
antibodi
singli
combin
enabl
differ
crystal
pack
lattic
format
around
bnab
start
discov
increas
number
variou
group
burton
nussenzweig
mascola
lab
identif
anoth
bnab
mark
connor
lab
led
increas
resolut
env
trimer
structur
use
combin
tri
mani
combin
antibodi
past
present
member
combin
proven
optim
far
enabl
resolut
structur
gradual
increas
clade
sosip
trimer
thu
complet
model
env
trimer
obtain
greater
definit
structur
featur
includ
welldefin
glycan
particularli
surround
bnab
construct
includ
nfl
trimer
crystal
structur
determin
clade
c
trimer
well
clade
b
clade
g
sosip
trimer
detail
pleas
see
electron
microscopi
critic
develop
sosip
platform
describ
cryoelectron
microscopi
cryoem
howev
play
increas
role
highresolut
structur
determin
hiv
env
complex
bnab
emerg
primari
driver
investig
viral
antigen
complex
antibodi
exampl
unlik
xray
crystallographi
cryoem
advantag
independ
crystal
format
lattic
contact
thu
inher
advantag
glycan
engin
although
analysi
heterogen
glycosyl
site
potenti
pose
problem
unambigu
structur
interpret
howev
signific
advantag
complex
prevent
protein
crystal
actual
enhanc
singl
particl
data
analysi
due
requir
comput
align
classifi
cryoem
imag
particl
featur
target
particl
possess
greater
abil
identifi
sort
align
particl
comput
fidel
therefor
better
result
resolut
approach
particularli
power
hiv
field
complex
target
multipl
fab
greatli
facilit
structur
determin
env
analysi
bnab
epitop
low
resolut
negativestain
em
power
method
rapidli
map
epitop
bnab
limit
resolut
preclud
explicit
atomiclevel
descript
howev
hybrid
integr
model
accomplish
dock
crystal
structur
compon
given
env
trimerantibodi
complex
em
reconstruct
enhanc
molecular
inform
obtain
exampl
approach
allow
descript
quaternari
epitop
apex
target
antibodi
complex
reveal
like
interact
symmetryrel
apex
glycan
two
protom
trimer
model
howev
replac
explicit
highresolut
structur
determin
solv
first
highresolut
cryoem
structur
solubl
hiv
env
trimer
structur
mileston
field
began
reveal
atom
detail
intact
env
trimer
associ
glycan
nevertheless
resolut
limit
despit
use
direct
electron
detector
help
revolution
cryoem
next
big
advanc
came
combin
direct
electron
detector
titan
krio
electron
microscop
result
resolut
reconstruct
first
cryoem
map
atom
level
detail
nativ
glycosyl
trimer
subsequ
improv
sampl
prepar
data
collect
graphic
process
unit
gpu
enabl
imag
process
algorithm
achiev
resolut
dataset
mani
part
cryoem
map
env
resolv
better
atom
featur
uncov
high
detail
anoth
advantag
cryoem
singl
particl
data
submit
rigor
classif
use
program
relion
separ
structur
heterogen
trimer
substoichiometr
occup
bound
antibodi
thu
singl
data
set
envbnab
complex
typic
deconvolut
multipl
cryoem
reconstruct
complet
accur
portray
actual
ensembl
complex
solut
use
approach
show
site
direct
bnab
bound
sosip
trimer
variabl
occup
averag
stoichiometri
two
per
trimer
fab
bound
solutionbas
approach
isotherm
titrat
calorimetri
itc
also
use
measur
occup
result
similar
substoichiometr
valu
clear
advantag
cryoem
distribut
occup
conform
state
resolv
particular
case
deglycosyl
env
trimer
increas
stoichiometri
suggest
glycan
heterogen
like
surround
led
protom
fab
bound
glycan
env
compris
approxim
mass
trimer
larg
flexibl
disord
absenc
bnab
partial
immobil
glycan
cognat
epitop
henc
typic
observ
first
two
sugar
residu
given
png
absenc
antibodi
interact
notabl
except
png
contrast
glycan
project
trimer
surfac
lay
flat
groov
resolv
evid
identif
disord
glycan
observ
cryoem
map
contour
low
level
lowpass
filter
map
similar
observ
sometim
made
xray
map
glycoprotein
contour
lower
resolut
resolv
glycan
part
bnab
epitop
usual
consist
analog
xray
structur
although
crystallograph
structur
deriv
env
trimer
produc
exclus
high
mannos
glycan
treat
glycosidas
antibodi
complex
format
remov
access
glycan
promot
crystal
aforement
flexibl
glycan
xray
cryoem
map
envantibodi
complex
quit
similar
core
glcnac
mannos
moieti
common
glycan
structur
complexspecif
sugar
moieti
core
fucos
branch
galactos
sialic
acid
rare
resolv
cryoem
map
although
except
includ
visual
biantennari
tetraantennari
structur
final
build
refin
glycan
structur
densiti
map
whether
em
xray
remain
difficult
great
need
improv
algorithm
autom
cryoem
clear
advantag
xray
crystallographi
examin
membranebound
nativ
viral
spike
small
amount
materi
purifi
hydrophob
transmembran
region
tend
flexibl
lead
micel
format
aggreg
studi
demonstr
membraneteth
measur
impact
protein
structur
sosip
mutat
perturb
protein
nativ
prefus
state
recent
find
ad
structur
valid
use
solubl
sosip
vaccin
strategi
overal
xray
crystallograph
cryoem
analys
env
trimer
display
engin
glycan
glycan
engin
use
suggest
protein
structur
independ
glycan
process
henc
env
trimer
toler
signific
degre
glycan
heterogen
preval
glycan
within
epitop
bnab
env
motiv
examin
precis
chemic
composit
env
glycan
central
vaccin
strategi
aim
elicit
glycantarget
antibodi
recombin
immunogen
display
glycan
suffici
resembl
individu
process
state
nativ
virion
result
antiglycan
antibodi
respons
crossreact
neutral
viru
establish
tenet
glycobiolog
fine
process
complextyp
glycosyl
heavili
influenc
produc
cell
type
prevail
physiolog
condit
howev
extrem
challeng
isol
nativ
virion
infect
individu
glycan
glycopeptid
analysi
reason
analysi
initi
restrict
recombin
monomer
eventu
proceed
trimer
nativelik
sosip
membraneteth
env
trimer
virus
produc
differ
cell
system
antigen
crossreact
lead
recombin
trimer
glycanbind
bnab
indic
ident
glycan
recombin
immunogen
use
infer
glycan
structur
nativ
viru
crossreact
formal
identifi
nativ
glycan
target
howev
demonstr
recombin
immunogen
bear
glycan
could
conceiv
elicit
similar
crossreact
antiglycan
antibodi
two
main
approach
use
understand
composit
glycan
shield
immunogen
viru
analysi
releas
glycan
analysi
glycopeptid
latter
approach
provid
sitespecif
inform
necessari
reveal
chemic
conform
precis
antibodi
epitop
howev
much
inform
garner
initi
evalu
pool
enzymat
releas
glycan
analysi
glycan
gel
band
pseudovirion
peripher
blood
mononuclear
cell
pbmc
deriv
virion
show
viru
domin
oligomannosetyp
glycan
provid
import
benchmark
evalu
candid
immunogen
mass
spectrometri
influenc
glycan
charg
necessarili
quantit
contrast
ultraand
highperform
liquid
chromatographi
uplc
hplc
fluoresc
label
glycan
enabl
unbias
profil
glycan
addit
abund
oligomannosetyp
glycan
featur
readili
assess
compar
parent
glycan
pool
glycan
digest
case
oligomannosespecif
endoglycosidas
endo
h
method
use
demonstr
format
significantli
higher
content
oligomannosetyp
glycan
compar
oligomer
env
format
foldon
uncleav
trimer
analysi
glycopeptid
requir
use
mass
spectrometri
howev
methodolog
yield
result
contradict
known
glycan
structur
structur
antigen
inform
discrep
aris
like
due
lack
quantit
ioniz
overrepresent
minor
speci
differenti
ioniz
one
sourc
error
principl
adopt
data
analysi
softwar
also
imped
quantit
analysi
exampl
mani
softwar
packag
util
ion
count
rather
ion
intens
evalu
ion
abund
sitespecif
analysi
inlin
lcm
analysi
implement
benchmark
ms
isol
glycopeptid
fraction
overal
analys
close
agreement
two
approach
analysi
glycosyl
site
contain
exclus
oligomannosetyp
glycan
almost
exclus
complextyp
glycan
rang
structur
term
mix
site
abil
quantifi
abund
glycan
led
assess
impact
differ
protein
architectur
glycan
process
impact
trimer
glycosyl
impact
lack
furincleavag
matur
glycan
shield
nonquantit
analysi
glycopeptid
also
found
util
captur
major
speci
present
virionderiv
anoth
import
develop
glycan
array
particularli
use
assess
glycan
bind
properti
bnab
current
array
larg
assort
glycan
interrog
bind
receptor
protein
sever
array
avail
one
commonli
use
develop
jim
paulson
chihuey
wong
other
made
gener
avail
consortium
function
glycom
recent
version
contain
extend
airway
glycan
includ
extend
polynacetyllactosamin
polylacnac
chain
present
highthroughput
analysi
glycan
array
neoglycolipid
array
aluminum
oxideco
glass
slide
array
also
develop
glycan
major
compon
bnab
epitop
bind
seen
bnab
array
hand
even
though
glycan
typic
part
bnab
epitop
sometim
readili
visual
glycan
array
bind
weak
requir
glycan
cluster
epitop
intim
involv
glycanprotein
interfac
one
first
exampl
hiv
field
antibodi
bind
exclus
high
mannos
glycan
next
exampl
also
bind
high
mannos
sugar
recognit
complex
glycan
also
observ
antibodi
env
trimer
apex
bind
lower
trimer
glycan
less
dens
process
readili
complet
complextyp
sugar
inde
branch
bito
tetraantennari
glycan
visual
cryoem
jrfl
trimer
mammal
humor
cellular
innat
immun
system
readili
recognis
activ
expos
oligomannosetyp
glycan
convers
golgi
apparatu
oligomannoseto
complextyp
glycan
self
glycoprotein
consequ
highli
effici
rare
exampl
document
secret
cellsurfac
self
glycoprotein
present
oligomannosetyp
glycan
typic
occur
structur
hinder
site
diseas
patholog
integr
secretori
system
may
compromis
contrast
self
glycoprotein
analysi
glycan
recombin
identifi
minor
popul
oligomannos
structur
extens
analysi
repeatedli
confirm
popul
varieti
recombin
monom
oligomannosetyp
glycan
cluster
within
heavili
glycosyl
region
outer
domain
coin
intrins
mannos
patch
imp
abund
oligomannosetyp
glycan
imp
less
observ
virionsderiv
env
led
hypothesi
addit
trimerassoci
mannos
patch
tamp
support
tamp
profil
releas
glycan
panel
oligomer
immunogen
demonstr
trimer
compact
structur
display
threefold
symmetri
along
trimer
axi
exhibit
elev
level
oligomannosetyp
glycan
find
establish
quaternari
structur
constraint
import
drive
format
nativ
mannos
patch
env
one
extrem
display
oligomannosetyp
glycan
wherea
foldon
trimer
suggest
littl
quaternari
constraint
glycan
process
impos
foldoninduc
oligomer
notion
consist
em
analysi
suggest
abund
nativelik
materi
foldon
trimer
neglig
despit
convinc
observ
contradictori
cryoem
analysi
report
use
argu
foldon
adopt
nativelik
fold
conflict
like
result
imposit
threefold
symmetri
data
process
reflect
foldon
trimer
popul
may
also
explain
highresolut
reconstruct
could
achiev
one
control
experi
shed
light
issu
quantit
sitespecif
analysi
perform
monom
uncleav
oligom
analysi
reveal
conserv
imp
across
differ
format
indic
similar
process
glycan
show
trimer
display
significantli
elev
content
oligomannosetyp
glycan
defin
tamp
along
protom
interfac
glycan
analysi
therefor
consider
role
complement
cryoem
xray
crystallographi
evalu
candid
trimer
immunogen
high
content
oligomannosetyp
glycan
togeth
observ
order
compact
structur
hallmark
correctli
fold
nativelik
env
materi
complementari
approach
use
assess
grow
number
candid
immunogen
assess
impact
protein
engin
strategi
conserv
mannos
patch
import
implic
immunogen
design
evalu
glycosyl
enabl
triag
immunogen
candid
conserv
mannos
patch
suggest
larg
insensit
mutat
effect
frequenc
distribut
glycan
mannos
patch
resili
chang
glycosyl
posit
frequenc
answer
lie
extent
substrat
recognit
interfac
er
golgi
crystal
structur
deactiv
er
complex
oligomannos
substrat
dock
onto
structur
env
contain
glycan
resid
centr
imp
enzym
result
model
complex
complet
envelop
three
neighbor
glycan
support
simpl
model
enzym
inaccess
prevent
canon
glycan
matur
importantli
extent
redund
clash
suggest
mutat
would
unlik
impact
process
neighbor
glycan
structur
model
support
glycan
profil
select
sitespecif
analysi
monom
contain
glycan
site
mutat
final
enzymat
inaccess
glycan
reveal
vitro
model
matur
engin
glycoform
incub
er
overal
conclud
mimicri
protein
structur
recombin
trimer
function
env
spike
similarli
drive
mimicri
glycan
shield
wherea
may
true
glycosyl
site
present
steric
protect
oligomannosetyp
structur
hold
site
display
complextyp
glycan
enzymat
answer
question
two
hierarchi
one
level
branch
exampl
biantennari
versu
triantennari
glycan
type
abund
termin
structur
sialyl
fucosyl
even
polylactosamin
extens
analysi
pbmcderiv
env
ionmobl
ms
hplc
suggest
content
oligomannosetyp
glycan
similar
observ
format
process
glycan
diverg
degre
process
particular
abund
sialyl
structur
notabl
also
domin
rather
typic
observ
human
embryon
kidney
hek
chines
hamster
ovari
cho
express
system
importantli
recombin
neglig
polylactosamin
structur
characterist
macrophagederiv
env
signific
structur
diverg
result
polylactosamin
extens
underscor
conclus
recombin
trimer
may
reliabl
recapitul
mannos
patch
nativ
trimer
celldepend
variat
complextyp
structur
may
limit
util
target
epitop
contain
complextyp
glycan
concern
underscor
reduc
sensit
antibodymedi
neutral
isogen
viru
deriv
macrophag
compar
pbmc
nevertheless
bnab
definit
abl
target
multipl
strain
subtyp
also
also
larg
cope
glycan
heterogen
bnab
greatest
breadth
like
explan
compon
glycan
recogn
common
glycoform
name
glcnacmannos
core
sever
case
born
interact
seen
core
sugar
bnab
cryoem
xray
structur
case
limit
deal
glycan
heterogen
underscor
observ
neutral
plateau
increas
bnab
concentr
fail
complet
neutral
viru
find
interpret
evid
glycan
heterogen
lead
popul
resist
virus
support
notion
neutral
plateau
often
influenc
glycan
engin
target
viru
exampl
even
antibodi
target
imp
display
incomplet
neutral
plateau
virion
display
presenc
kifunensin
render
resist
neutral
addit
bind
substanti
impair
engin
glycoform
thu
vaccin
set
whether
natur
virus
design
immunogen
subtl
heterogen
glycan
target
affect
potenc
certain
antibodi
lineag
particular
epitop
futur
design
env
immunogen
may
explor
bear
greater
rang
complextyp
structur
entail
obtain
much
detail
understand
fine
glycan
structur
present
virion
nativ
infecti
set
coupl
concomit
advanc
express
env
immunogen
display
bespok
glycoform
bnab
interact
glycan
varieti
way
core
nacetylglucosamin
extend
branch
high
mannos
complex
glycoform
figur
glycan
structur
inform
typic
complet
resolv
sever
structur
bound
bnab
eg
flexibl
within
glycan
structur
demonstr
rel
rigid
locat
center
dens
glycosyl
mannos
patch
outer
domain
figur
fact
dens
glycosyl
sugar
process
enzym
steric
exclud
access
glycan
therebi
endow
restrict
charact
high
mannos
patch
patch
conserv
across
multipl
hiv
env
subtyp
function
trimer
quaternari
structur
env
independ
purif
method
long
nativelik
prefus
env
construct
express
prototyp
exampl
bind
high
mannos
glycan
almost
sugar
glycan
interact
antibodi
crystal
structur
fab
pgt
bound
glycan
could
resolv
ultrahigh
resolut
respect
indic
glycan
bound
low
energi
conform
associ
stabil
water
molecul
sugar
moieti
glycan
complex
structur
engin
outer
domain
eod
illustr
bound
glycan
also
case
core
sugar
figur
compar
small
linear
region
protein
base
loop
interact
specif
fab
antibodi
crystal
structur
loop
observ
includ
latter
two
recogn
singl
glycan
compar
antibodi
interact
two
glycan
glycan
also
observ
em
reconstruct
bnab
trimer
apex
character
conserv
glycan
project
upward
critic
compon
bnab
other
earli
crystal
structur
complex
small
scaffold
piec
env
apex
reveal
glycan
sialat
respect
figur
structur
anoth
apextarget
bnab
complex
scaffold
express
gntidefici
cell
line
similar
structur
reveal
yet
anoth
view
glycan
figur
recent
cryoem
structur
sosip
express
cell
complex
interpret
glycan
long
anion
betahairpin
heavi
chain
complementar
determin
penetr
glycan
triad
interact
primarili
one
glycan
figur
exampl
illustr
exquisit
subtleti
present
understand
glycan
bind
bnab
help
resolv
glycan
andor
induc
conform
differ
orient
modifi
trior
tetraantennari
complex
glycan
core
fucosyl
jrfl
deltact
complex
extens
interact
termin
branch
glycan
well
core
sugar
moieti
includ
fucos
attach
first
glcnac
sugar
figur
diversityheterogen
complex
interact
may
respons
lower
breadth
achiev
bnab
plateau
observ
incomplet
neutral
curv
henc
bnab
evolv
accommod
glycan
includ
engag
conserv
base
glycan
negoti
flexibl
heterogen
branch
figur
extens
somat
hypermut
mani
bnab
becom
depend
glycan
bind
remov
glycan
result
increas
offrat
weaker
bind
affin
eg
other
like
famili
bnab
oblig
glycan
binder
littl
affin
abil
neutral
absenc
certain
glycan
trend
across
subtyp
glycan
depend
hold
across
subtyp
exampl
glycan
remov
proxim
glycan
act
surrog
eg
receptor
glycan
clear
impedi
bind
env
trimer
receptor
contain
immunoglobulin
fold
resembl
heavi
chain
antibodi
mani
bnab
therefor
use
receptor
mimicri
recognit
howev
presenc
light
chain
creat
addit
steric
hurdl
sever
restrict
permiss
angl
approach
bind
effort
circumv
hurdl
elicit
bnab
includ
minim
epitop
present
outright
remov
glycan
sever
glycan
act
steric
barrier
critic
glycan
interact
light
chain
bnab
requir
unusu
short
accommod
glycan
bnab
becom
depend
glycan
delet
result
loss
affin
neutral
howev
elicit
germlin
gl
antibodi
requir
remov
gl
trimer
epitopescaffold
protein
immun
requir
ad
back
delet
glycan
enabl
evolut
elicit
gl
antibodi
achiev
recognit
nativ
virion
full
constel
glycan
glycan
truli
steric
barrier
normal
silenc
suppress
immun
respons
env
beauti
shown
rabbit
vaccin
experi
use
sosip
trimer
primari
neutral
respons
trimer
rare
glycan
hole
env
trimer
expos
peptid
trimer
base
neoepitop
solubl
sosip
trimer
also
preferenti
target
nonneutr
antibodi
studi
highlight
prefer
adapt
immun
respons
protein
epitop
glycancontain
epitop
hurdl
inher
hiv
vaccin
design
strategi
knockout
particular
glycan
prime
immunogen
reintroduc
subsequ
boost
immunogen
activ
area
research
help
overcom
challeng
substanti
progress
made
recent
character
extens
glycan
shield
hiv
thought
mani
year
glycan
coat
provid
impenetr
barrier
immun
system
howev
densiti
nlink
glycosyl
hiv
trimer
far
exce
anyth
human
protein
furthermor
limit
heterogen
glycan
hiv
exceedingli
high
densiti
mani
glycan
stall
incomplet
process
high
mannos
sugar
rel
homogen
env
surfac
result
glycan
expos
domain
rel
conserv
particularli
imp
although
self
glycan
rel
immunosil
inde
use
diminish
immunodomin
epitop
overwhelm
densiti
proxim
viral
protein
compon
render
target
immun
system
although
immun
respons
heavili
glycosyl
protein
hiv
rel
weak
time
antibodi
develop
recogn
sugar
peptid
compon
glycoprotein
inde
almost
bnab
hiv
contact
attempt
circumnavig
glycan
becom
integr
part
bnab
epitop
glycan
aid
elucid
env
structur
complex
bnab
recogn
glycan
instrument
determin
initi
xray
em
structur
crystal
lattic
contact
ad
mass
featur
cryoem
particl
align
resolut
approach
extens
use
sinc
deciph
wide
rang
broadli
neutral
epitop
viral
surfac
character
glycan
prove
challeng
context
env
protein
structur
also
analyt
dissect
composit
glycan
glycosyl
site
protein
method
advanc
whole
new
chapter
written
recent
analysi
hiv
glycan
shield
question
whether
solubl
sosip
protein
express
glycoform
membranebound
version
also
recent
address
well
challeng
question
glycoform
express
env
viru
differ
cell
line
particular
cell
subtl
differ
seem
aris
env
glycosyl
known
whether
variat
critic
elicit
broadli
neutral
respons
solubl
immunogen
whether
membranebound
construct
ultim
requir
notwithstand
bnab
isol
hivinfect
individu
bind
strongli
solubl
env
construct
explain
part
antibodi
recognit
core
compon
glycan
essenti
ident
high
mannos
hybrid
complex
glycan
differ
aris
fucosyl
first
nacetylglucosamin
complex
glycan
heterogen
complex
glycan
play
role
achiev
neutral
plateau
effect
neutral
assay
observ
certain
bnab
certain
virus
howev
look
back
consid
difficult
challeng
gain
even
limit
inform
glycan
shield
come
long
way
last
year
progress
rapid
env
construct
analys
look
similar
differ
glycosyl
differ
strain
subtyp
comparison
env
protein
viru
glycan
shield
still
barrier
overcom
natur
infect
vaccin
vaccin
trial
anim
model
alreadi
illustr
small
breach
glycan
shield
exploit
immun
system
hole
tend
viral
isol
specif
give
rise
neutral
breadth
fill
glycan
hole
well
creat
new
hole
engag
desir
germlin
antibodi
current
explor
without
question
qualiti
quantiti
inform
amass
last
year
glycan
shield
use
varieti
biophys
method
quit
astound
har
ever
increas
compendium
structur
function
knowledg
hiv
env
glycoprotein
aid
design
truli
effect
hiv
vaccin
coss
kp
vasiljev
pritchard
glycan
moieti
interact
strongli
bnab
heavi
dark
gray
light
light
gray
chain
typic
well
resolv
crystallograph
cryoem
map
fact
bind
high
mannos
well
structur
fab
alon
solv
crystallographi
pdb
resolv
figur
shown
c
heavi
chain
dark
gray
pdb
interfac
bnab
interact
minim
triantennari
complex
glycan
glycan
array
bind
data
suggest
glycan
may
contain
termin
sialic
acid
residu
indic
magenta
resolv
cryoem
map
heavi
chain
dark
gray
pdb
interact
termin
sialic
acid
hybridtyp
glycan
